Literature DB >> 28677092

Amelioration of bleomycin-induced pulmonary fibrosis by chlorogenic acid through endoplasmic reticulum stress inhibition.

Yi-Chun Wang1, Jing Dong2, Jing Nie2, Ji-Xiang Zhu2, Hui Wang3, Qiong Chen2, Jun-Yi Chen2, Jia-Mei Xia2, Wei Shuai2.   

Abstract

To investigate the inhibitory effects of chlorogenic acid on pulmonary fibrosis and the internal mechanisms in vivo and in vitro. 30 male BALB/C mice were randomized into 5 groups: control group, pulmonary fibrosis model group, low, middle and high dose of chlorogenic acid groups. Mice in pulmonary fibrosis model group were administered 5.0 mg/kg bleomycin with intracheal instillation and mice in 3 chlorogenic acid groups were treated with chlorogenic acid every day for 28 days after bleomycin administration. Lung tissue histology was observed using HE staining. Primary pulmonary fibroblasts were isolated and cultured. The expressions of fibrosis related factors (α-SMA and collagen I), as well as ER stress markers (CHOP and GRP78) were determined by both real-time PCR assay and Western blotting, while the expressions of other ER stress signaling pathway factors PERK, IRE-1, ATF-6 and protein levels of caspase-12, caspase-9, caspase-3, PARP were determined by Western blotting. RLE-6TN cell line induced by TGF-β1 was also used to verify the amelioration effects in vitro study. In both in vivo and in vitro studies, TUNEL staining was used to evaluate cell apoptosis. Expressions of collagen I, α-SMA, GRP78, and CHOP were significantly inhibited by chlorogenic acid in dose-dependent manner. Similarly, decreasing levels of cleaved caspase-12, caspase-9, caspase-3 and increasing level of uncleaved PARP were observed in chlorogenic acid groups compared with those in the fibrosis group both in vivo and in vitro. Chlorogenic acid could also significantly down-regulate the level of phosphorylation of PERK and cleaved ATF-6 in vivo study. Moreover, MTT assay demonstrated chlorogenic acid could enhance proliferation of RLE-6TN cells induced by TGFβ1 in vitro. And the apoptosis assays indicated that chlorogenic acid could significantly inhibit cell apoptosis both in vivo and in vitro studies. Chlorogenic acid could inhibit the pulmonary fibrosis through endoplasmic reticulum stress inhibition in vivo and in vitro.

Entities:  

Keywords:  Apoptosis; Bleomycin; Chlorogenic acid; Endoplasmic reticulum stress; Pulmonary fibrosis

Mesh:

Substances:

Year:  2017        PMID: 28677092     DOI: 10.1007/s10495-017-1393-z

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  10 in total

Review 1.  Oxidative and endoplasmic reticulum stress in respiratory disease.

Authors:  Alice C-H Chen; Lucy Burr; Michael A McGuckin
Journal:  Clin Transl Immunology       Date:  2018-06-13

2.  Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.

Authors:  Weibin Qian; Xinrui Cai; Qiuhai Qian; Wei Zhang; Dongli Wang
Journal:  J Cell Mol Med       Date:  2018-07-04       Impact factor: 5.310

3.  Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation.

Authors:  Ling Peng; Li Wen; Qing-Feng Shi; Feng Gao; Bin Huang; Jie Meng; Cheng-Ping Hu; Chang-Ming Wang
Journal:  Cell Death Dis       Date:  2020-11-13       Impact factor: 8.469

4.  Wenfei Buqi Tongluo Formula Against Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β/Smad3 Pathway.

Authors:  Lu Ding; Yaxin Li; Yingying Yang; Siyu Song; Hongyu Qi; Jing Wang; Ziyuan Wang; Jiachao Zhao; Wei Zhang; Linhua Zhao; Daqing Zhao; Xiangyan Li; Zeyu Wang
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

Review 5.  Chlorogenic acid: Potential source of natural drugs for the therapeutics of fibrosis and cancer.

Authors:  Ebuka-Olisaemeka Nwafor; Peng Lu; Ying Zhang; Rui Liu; Hui Peng; Bin Xing; Yiting Liu; Ziwei Li; Kuibin Zhang; Yukun Zhang; Zhidong Liu
Journal:  Transl Oncol       Date:  2021-11-30       Impact factor: 4.243

6.  Investigation of the Pharmacological Effect and Mechanism of Jinbei Oral Liquid in the Treatment of Idiopathic Pulmonary Fibrosis Using Network Pharmacology and Experimental Validation.

Authors:  Aijun Zhang; Yixuan Zou; Qingcui Xu; Shuo Tian; Jie Wang; Yilin Li; Renchao Dong; Liangzong Zhang; Juanjuan Jiang; Lili Wang; Kai Tao; Zhaoqing Meng; Yanqiu Liu
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

7.  Jinbei Oral Liquid ameliorates bleomycin-induced idiopathic pulmonary fibrosis in rats via reversion of Th1/Th2 shift.

Authors:  Xiao-Yan Xing; Wei-Jie Qiang; Jia-le Bao; Rui-Chuang Yang; Jun Hou; Kai Tao; Zhao-Qing Meng; Jing-Hua Zhang; Ai-Jun Zhang; Xiao-Bo Sun
Journal:  Chin Herb Med       Date:  2020-05-26

8.  Isorhamnetin protects against bleomycin-induced pulmonary fibrosis by inhibiting endoplasmic reticulum stress and epithelial-mesenchymal transition.

Authors:  Qing Zheng; Ming Tong; Baiqing Ou; Cuizhong Liu; Changping Hu; Yu Yang
Journal:  Int J Mol Med       Date:  2018-10-30       Impact factor: 4.101

9.  Attenuation of intermittent hypoxia-induced apoptosis and fibrosis in pulmonary tissues via suppression of ER stress activation.

Authors:  Zhihui Shi; Linhao Xu; Hui Xie; Ruoyun Ouyang; Ya Ke; Rui Zhou; Wing-Ho Yung
Journal:  BMC Pulm Med       Date:  2020-04-16       Impact factor: 3.317

10.  Artemisia gmelinii Attenuates Lung Inflammation by Suppressing the NF-κB/MAPK Pathway.

Authors:  Seung Yong Kim; Dong-Uk Shin; Ji-Eun Eom; Sun Young Jung; Hyeon-Ji Song; Kyung Min Lim; Gun-Dong Kim; Soon-Il Yun; Mi-Yeon Kim; Hee Soon Shin; So-Young Lee
Journal:  Antioxidants (Basel)       Date:  2022-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.